SCHEMBL30029680

SCHEMBL30029680

CC(C)(C)OC(=O)N1CCCC1C(O)c1cc(F)ccc1CCCO[Si](C)(C)C(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.36
▸ TSHR P16473 4/20 0.36
▸ LMNA P02545 4/20 0.36
▸ MEN1 O00255 3/20 0.36
▸ KMT2A Q03164 3/20 0.36
▸ NPSR1 Q6W5P4 3/20 0.36
▸ MAPT P10636 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ GPR119 Q8TDV5 1/20 0.34
▸ ALOX5AP P20292 1/20 0.34
▸ FEN1 P39748 1/20 0.34
▸ RIPK1 Q13546 1/20 0.34
▸ APP P05067 1/20 0.34
▸ HTR1A P08908 1/20 0.34
▸ ADRA2A P08913 1/20 0.34
▸ DRD2 P14416 1/20 0.34
▸ ADRA2B P18089 1/20 0.34
▸ ADRA2C P18825 1/20 0.34
▸ SLC6A2 P23975 1/20 0.34
▸ HRH2 P25021 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29565654 1.00 ALDH1A1 (0.36) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL17980086 1.00 ALDH1A1 (0.36) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL28449669 1.00 ALDH1A1 (0.36) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL17980088 1.00 ALDH1A1 (0.36) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL25400278 0.88 GPR119 (0.37) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL29765373 0.88 GPR119 (0.37) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL24080187 0.88 GPR119 (0.37) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL17980040 0.88 GPR119 (0.37) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL17980038 0.88 GPR119 (0.37) ALDH1A1TSHRLMNAMEN1KMT2A
SCHEMBL17980177 0.87 ALDH1A1 (0.40) ALDH1A1TSHRLMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240409550-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF SUMITOMO PHARMA AMERICA, INC. (US) 2024-12-12 — — US disclosed
EP-4464317-A2 COMPOUNDS AND COMPOSITIONS AND USES THEREOF Sumitomo Pharma America, Inc. (US) 2024-11-20 — — EP disclosed
EP-3494119-B1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF SUMITOMO PHARMA AMERICA INC (US) 2024-09-04 — — EP disclosed
US-11958862-B2 Compounds and compositions and uses thereof SUMITOMO PHARMA AMERICA, INC. (US) 2024-04-16 — — US disclosed
CN-116514761-A Compounds, compositions and uses thereof 赛诺维信制药公司 2023-08-01 — — CN disclosed
CN-116283877-A Compounds, compositions and uses thereof 赛诺维信制药公司 2023-06-23 — — CN disclosed
CN-110088107-B Compounds, compositions and uses thereof 赛诺维信制药公司 2023-04-14 — — CN disclosed
US-20220340588-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2022-10-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240409550-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF CHAT, ACHE, MAOB ALDH1A1 295/4885TSHR 3700/4885LMNA 1932/4885
US-11958862-B2 Compounds and compositions and uses thereof CHAT, ACHE, MAOB ALDH1A1 295/4885TSHR 3700/4885LMNA 1932/4885
US-20220340588-A1 COMPOUNDS AND COMPOSITIONS AND USES THEREOF CHAT, ACHE, MAOB ALDH1A1 295/4885TSHR 3700/4885LMNA 1932/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback